SKINVISIBLE, INC. (SKVI) — SEC Financial Statements & Analysis

SKINVISIBLE, INC. (SKVI) is a pharmaceutical preparations company, incorporated in NV. SKINVISIBLE, INC. trades on OTC as: SKVI. SKINVISIBLE, INC. (SKVI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, SKINVISIBLE, INC. carries a market cap of $1.15M, a P/E ratio of -1.11x, a P/B ratio of -0.11x, a P/S ratio of 57.44x, an enterprise value of $1.50M, and an EV/EBITDA multiple of -3.41x. On profitability, it posts a gross margin of 100.00%, an operating margin of -2294.90%, a net margin of -5156.60%, a Return on Equity (ROE) of 10.04%, and a Return on Assets (ROA) of -773.37%. Per share, it reports EPS of $-0.19, diluted EPS of $-0.11, free cash flow per share of $0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 0.00% year-over-year, net income growth of 95.60% year-over-year, and EPS growth of 95.60% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.00x, working capital of $-5.50M, a debt-to-equity ratio of -1.01x, a debt ratio of 88.45, an interest coverage ratio of -0.80x, free cash flow of $3.84K (TTM), and net debt of $348.12K. Figures sourced from SEC EDGAR.

Market Cap

$1.15M

P/E TTM

-1.11x

EPS TTM

$-0.19

P/B TTM

-0.11x

ROE TTM

10.04%

ROA TTM

-773.37%

Debt To Equity

-1.01x

Free Cash Flow TTM

$3.84K

Net Revenue TTM Growth 1Y

0.00%

Data as of 2026-06-30 · Source: SEC EDGAR